Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease.

Sun, Zijian; Chang, Binxia; Huang, Ang; Hao, Shuli; Gao, Miaomiao; Sun, Ying; Shi, Ming; Jin, Lei; Zhang, Wei; Zhao, Jun; Teng, Guangju; Han, Lin; Tian, Hui; Liang, Qingsheng; Zhang, Ji-Yuan; Zou, Zhengsheng

Sun, Zijian; Chang, Binxia; Huang, Ang; Hao, Shuli; Gao, Miaomiao; Sun, Ying; Shi, Ming; Jin, Lei; Zhang, Wei; Zhao, Jun; Teng, Guangju; Han, Lin; Tian, Hui; Liang, Qingsheng; Zhang, Ji-Yuan; Zou, Zhengsheng.

Afiliação

Sun Z; Center of Non-infectious Liver Diseases, Peking University 302 Clinical Medical School, Beijing, China.
Chang B; Center of Non-infectious Liver Diseases, Beijing 302 Hospital, Beijing, China.
Huang A; Center of Non-infectious Liver Diseases, Beijing 302 Hospital, Beijing, China.
Hao S; Center of Non-infectious Liver Diseases, Beijing 302 Hospital, Beijing, China.
Gao M; Center of Non-infectious Liver Diseases, Peking University 302 Clinical Medical School, Beijing, China.
Sun Y; Center of Non-infectious Liver Diseases, Beijing 302 Hospital, Beijing, China.
Shi M; Treatment and Research Center for Infectious Diseases, Beijing 302 Hospital, Beijing, China.
Jin L; Treatment and Research Center for Infectious Diseases, Beijing 302 Hospital, Beijing, China.
Zhang W; Center of Non-infectious Liver Diseases, Beijing 302 Hospital, Beijing, China.
Zhao J; Center of Non-infectious Liver Diseases, Beijing 302 Hospital, Beijing, China.
Teng G; Center of Non-infectious Liver Diseases, Beijing 302 Hospital, Beijing, China.
Han L; Center of Non-infectious Liver Diseases, Beijing 302 Hospital, Beijing, China.
Tian H; Center of Non-infectious Liver Diseases, Beijing 302 Hospital, Beijing, China.
Liang Q; Center of Non-infectious Liver Diseases, Beijing 302 Hospital, Beijing, China.
Zhang JY; Treatment and Research Center for Infectious Diseases, Beijing 302 Hospital, Beijing, China.
Zou Z; Center of Non-infectious Liver Diseases, Peking University 302 Clinical Medical School, Beijing, China.

J Cell Mol Med ; 23(2): 887-897, 2019 02.

Article em En | MEDLINE | ID: mdl-30478965

Assuntos

Doença Hepática Terminal/diagnóstico; Proteína 1 Semelhante a Receptor de Interleucina-1/genética; Interleucina-33/genética; Hepatopatias Alcoólicas/diagnóstico; Fígado/metabolismo; Adulto; Idoso; Biomarcadores/sangue; Estudos de Casos e Controles; Progressão da Doença; Doença Hepática Terminal/sangue; Doença Hepática Terminal/complicações; Doença Hepática Terminal/genética; Humanos; Proteína 1 Semelhante a Receptor de Interleucina-1/sangue; Interleucina-33/sangue; Lipopolissacarídeos/farmacologia; Fígado/patologia; Hepatopatias Alcoólicas/sangue; Hepatopatias Alcoólicas/complicações; Hepatopatias Alcoólicas/genética; Testes de Função Hepática; Masculino; Pessoa de Meia-Idade; Monócitos/citologia; Monócitos/efeitos dos fármacos; Monócitos/metabolismo; Prognóstico; Índice de Gravidade de Doença; Solubilidade; Fator de Necrose Tumoral alfa/sangue; Fator de Necrose Tumoral alfa/genética

Palavras-chave

alcoholic liver disease; interleukin-33; monocyte; sST2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google